BluePath Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.6M | Buy |
14,034
+2,337
| +20% | +$434K | 1.27% | 14 |
|
|
2025
Q1 | $2.45M | Buy |
11,697
+539
| +5% | +$113K | 1.42% | 13 |
|
|
2024
Q4 | $1.97M | Buy |
11,158
+1,902
| +21% | +$336K | 1.06% | 18 |
|
|
2024
Q3 | $1.83M | Buy |
9,256
+30
| +0.3% | +$5.92K | 1.13% | 18 |
|
|
2024
Q2 | $1.58M | Buy |
9,226
+1,915
| +26% | +$328K | 1.11% | 16 |
|
|
2024
Q1 | $1.33M | Buy |
7,311
+67
| +0.9% | +$12.2K | 1% | 16 |
|
|
2023
Q4 | $1.19M | Buy |
7,244
+1,051
| +17% | +$173K | 1.02% | 15 |
|
|
2023
Q3 | $923K | Buy |
+6,193
| New | +$923K | 0.85% | 17 |
|